The Lancet Oncology

@TheLancetOncol · London, NYC, Munich, Beijing · joined 24 Jun 2009

The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.

61 520Followers

418Following

10 746Posts total

18.5KViews on collected posts

Últimas publicaciones

The Lancet Oncology@TheLancetOncol16 Sep

🗓️@TheLancetOncol sessions to look out for at #WCC2026 in Hong Kong, Sept 24 to 26, 2026! 🥼Developing the Global Cancer Workforce and System Impact, 24th 🧑‍🤝‍🧑The Human Crisis in Cancer, 25th 🧬Accelerating Equitable Cancer Genomics, 25th https://t.co/wNvNcW0FpY https://t.co/

702 views · 5 likes · 2 reposts · 1 replies Open on X →

The Lancet Oncology@TheLancetOncol14 Sep

🔴Online now: Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial https://t.co/QLh1XmqC5H https://t.co/WWVbGPXYuf

2.2K views · 7 likes · 5 reposts · 1 replies Open on X →

The Lancet Oncology@TheLancetOncol10 Sep

Heading to @IASLC 2026 World Conference on Lung Cancer? - So are we! Reach out to Senior Editor, Dr Patodia, attending #WCLC26 and say hello! https://t.co/bWtAYnTgXp

2.1K views · 6 likes · 2 reposts · 1 replies Open on X →

The Lancet Oncology@TheLancetOncol10 Sep

📽️Watch our video abstract: Unpicking the UK's cancer response after Brexit: what broke, what was patched up, and what still matters Read the full Essay in @TheLancetOncol by @markgdayan and Martin McKee https://t.co/9kXExjY1s2 3.4K views · 1 likes · 1 reposts · 0 replies Open on X →

The Lancet Oncology@TheLancetOncol25 Aug

🆕Our Sept issue is now live! 📊Articles: #hepatocellularcarcinoma #NSCLC #rectalcancer #breastcancer #prostatecancer 📉Featuring trials: EMERALD-3, HARMONi, ALINA, STAR-TREC, & GETUG AFU 18 🎨Cover: breast cancer, TILs, and AI 🖱️Read here: https://t.co/wBTWK8skQe https://t.c

10.1K views · 26 likes · 14 reposts · 2 replies Open on X →

Frente a cuentas del mismo tamaño

5 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. alcance normal para su tamaño, reacción más débil que la mayoría.

Visualizaciones medianas2 198esta cuenta924mediana de 10K–100K

Alcance, %3.57%esta cuenta3.62%mediana de 10K–100K

Interacción, %0.47%esta cuenta1.52%mediana de 10K–100K

Métrica	Esta cuenta	Mediana de 10K–100K	Proporción
Visualizaciones medianas por publicación	2 198	924	2.38×
Alcance (visualizaciones ÷ seguidores)	3.57%	3.62%	0.99×
Tasa de interacción	0.47%	1.52%	0.31×

Otras cuentas de este rango → Comparar con otra cuenta → Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

10.1K25 Aug

3.4K10 Sep

2.1K

2.2K14 Sep

70216 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.47%25 Aug

0.06%10 Sep

0.42%

0.59%14 Sep

1.14%16 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes51.1%45 in total

Reposts27.3%24 in total

Replies5.7%5 in total

Quotes5.7%5 in total

Bookmarks10.2%9 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

9 Sep

Daily snapshots since 09 Sep 2026; the dashed line is the starting count.